Quality of life and outcome in stage IV non-small cells lung cancer patients : A prospective study.
Not Applicable
Completed
- Conditions
- Cancer
- Registration Number
- PACTR202104725647601
- Lead Sponsor
- service de pneumologie Pavillon 4
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Confirmed NSCLC with histological proof.
Written informed consent
Exclusion Criteria
Other comorbidities associated to NSCLC which interfere with quality of life
Anterior sleep disturbance known before lung cancer diagnosis
Pharmacological treatment interfering with sleep quality
Severe pain with intensity in visual analogical scale (VAS) greater than 6/10, leading to prescription of oral opioïd therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence quality of life in stage IV non-small cell lung cancer patients?
How does this interventional study compare to standard-of-care treatments for advanced NSCLC in terms of survival outcomes and symptom management?
Are there specific biomarkers associated with improved prognosis or treatment response in stage IV lung cancer as identified in recent trials?
What adverse events are commonly reported in stage IV NSCLC trials evaluating quality of life interventions, and how are they managed?
What combination therapies or emerging drugs show promise in enhancing quality of life for metastatic non-small cell lung cancer patients?